Analgesics - South America

  • South America
  • In South America, the revenue in the Analgesics market in 2024 amounts to US$2.22bn.
  • It is projected to grow annually by 6.21% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue with US$7,243.00m in 2024.
  • In terms of per person revenues, in South America generates US$5.38 in 2024.
  • In South America, there is a growing demand for natural and herbal analgesics in the OTC Pharmaceuticals market.

Key regions: Canada, United States, United Kingdom, Australia, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in South America is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trajectory.Customer preferences in South America are driving the growth of the Analgesics market. Consumers in this region are increasingly prioritizing their health and well-being, leading to a higher demand for pain relief products. Additionally, there is a growing awareness and acceptance of over-the-counter medications, which further fuels the demand for analgesics.Trends in the market also contribute to the development of the Analgesics market in South America. One notable trend is the increasing availability and accessibility of analgesics in various retail channels. Pharmacies, supermarkets, and online platforms are expanding their product offerings, making it easier for consumers to purchase analgesics. This trend is particularly important in South America, where access to healthcare services can be limited in some areas.Another trend in the market is the introduction of innovative analgesic products. Manufacturers are constantly developing new formulations and delivery methods to meet the evolving needs of consumers. This includes the introduction of fast-acting pain relief products and those specifically designed for certain types of pain. These innovations not only attract new customers but also encourage existing customers to continue using analgesics.Local special circumstances also play a role in the development of the Analgesics market in South America. The region has a relatively young population, and with increasing urbanization and changing lifestyles, the incidence of pain-related conditions is on the rise. This creates a higher demand for analgesics as individuals seek relief from various types of pain, including headaches, muscle aches, and joint pain.Underlying macroeconomic factors further contribute to the growth of the Analgesics market in South America. Economic stability and rising disposable incomes enable consumers to afford analgesics and other healthcare products. Additionally, improvements in healthcare infrastructure and access to healthcare services contribute to the overall growth of the market.In conclusion, the Analgesics market in South America is developing due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. As consumers prioritize their health and well-being, the demand for analgesics continues to grow. The increasing availability of analgesics in various retail channels, along with the introduction of innovative products, further supports this growth. Additionally, the region's young population, changing lifestyles, and economic stability contribute to the positive trajectory of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)